Publication | Closed Access

Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results

Advanced Breast CancerBreast OncologyOncologyMedicineHigh-dose Folinic AcidBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentFirst-line ChemotherapyPharmacologyRadiation OncologyCancer Research